Clinical Trial Update: Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating curcumin therapy for impaired glucose tolerance and insulin resistance in people with Type 2 diabetes and pre-diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Pre-diabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Srinakharinwirot University | Conditions: Type 2 Diabetes, Pre-diabetes | Phase 4 | Status: UNKNOWN